Reckon Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 14-12-2024
- Paid Up Capital ₹ 2.50 Cr
as on 14-12-2024
- Company Age 40 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.22 Cr
as on 14-12-2024
- Revenue -5.41%
(FY 2023)
- Profit -20.91%
(FY 2023)
- Ebitda -31.35%
(FY 2023)
- Net Worth 5.35%
(FY 2023)
- Total Assets 14.83%
(FY 2023)
About Reckon Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.50 Cr.
The company currently has active open charges totaling ₹10.22 Cr.
Nital Patel and Payal Patel serve as directors at the Company.
- CIN/LLPIN
U67120GJ1984PTC007400
- Company No.
007400
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Oct 1984
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Reckon Diagnostics Private Limited offer?
Reckon Diagnostics Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, IVDs & Analyzers, Rapid Test Kit, Textile, Dyeing & Finishing Chemical, Textile Chemical.
Who are the key members and board of directors at Reckon Diagnostics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nital Patel  | Managing Director | 01-Jan-1999 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Payal Patel | Whole-Time Director | 15-Jan-2008 | Current |
Financial Performance of Reckon Diagnostics.
Reckon Diagnostics Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.41% decrease. The company also saw a substantial fall in profitability, with a 20.91% decrease in profit. The company's net worth moved up by a moderate rise of 5.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reckon Diagnostics?
Unlock access to Reckon Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kaavya Cera Coat Private LimitedActive 37 years 9 monthsNital Patel and Payal Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 05 Sep 2022 | ₹1.42 Cr | Open |
Others Creation Date: 30 Nov 2021 | ₹5.20 M | Open |
Others Creation Date: 28 Oct 2020 | ₹1.04 Cr | Open |
How Many Employees Work at Reckon Diagnostics?
Reckon Diagnostics has a workforce of 200 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reckon Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reckon Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
